The Impact of Trimetazidine Treatment on Left Ventricular Functions and Plasma Brain Natriuretic Peptide Levels in Patients with Non-ST Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

DEMIRELLI S., KARAKELLEOĞLU Ş., GÜNDOĞDU F., TAŞ M. H., Kaya A., Duman H., ...Daha Fazla

KOREAN CIRCULATION JOURNAL, cilt.43, sa.7, ss.462-467, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 7
  • Basım Tarihi: 2013
  • Doi Numarası: 10.4070/kcj.2013.43.7.462
  • Dergi Adı: KOREAN CIRCULATION JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.462-467
  • Anahtar Kelimeler: Natriuretic peptide, brain, Percutaneous coronary intervention, Trimetazidine, FATTY-ACID OXIDATION, HEART-FAILURE, ARTERY-DISEASE, TRIMPOL-II, ANGINA, ISCHEMIA
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Background and Objectives: The aim of this study was to investigate the impact of treatment with oral trimetazidine (TMZ) applied before and after percutaneous coronary interventions (PCI) on short-term left ventricular functions and plasma brain natriuretic peptide (BNP) levels in patients with non-ST segment elevation myocardial infarction (NSTEMI) undergoing PCI.